Zobrazeno 1 - 10
of 54
pro vyhledávání: '"SANJU IWAMOTO"'
Autor:
Naoko Sawada, Takashi Obama, Shinji Koba, Takashi Takaki, Sanju Iwamoto, Toshihiro Aiuchi, Rina Kato, Masaki Kikuchi, Yuji Hamazaki, Hiroyuki Itabe
Publikováno v:
Journal of Lipid Research, Vol 61, Iss 6, Pp 816-829 (2020)
Oxidized LDL (oxLDL) is a known risk factor for atherogenesis. This study aimed to reveal structural features of oxLDL present in human circulation related to atherosclerosis. When LDL was fractionated on an anion-exchange column, in vivo-oxLDL, dete
Externí odkaz:
https://doaj.org/article/ab84766f6d904cca9467842094fec8c2
Autor:
Takashi Obama, Hitomi Ohinata, Takashi Takaki, Sanju Iwamoto, Naoko Sawada, Toshihiro Aiuchi, Rina Kato, Hiroyuki Itabe
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The function of oxidatively modified low-density lipoprotein (oxLDL) in the progression of cardiovascular diseases has been extensively investigated and well-characterized with regards to the activation of multiple cellular responses in macrophages a
Externí odkaz:
https://doaj.org/article/6d31fc7fb5724d3e909123d776131799
Autor:
Naoko Sawada, Takashi Obama, Mirei Mizuno, Kiyoshi Fukuhara, Sanju Iwamoto, Toshihiro Aiuchi, Tomohiko Makiyama, Hiroyuki Itabe
Publikováno v:
Antioxidants, Vol 9, Iss 11, p 1045 (2020)
Oxidized low-density lipoprotein (oxLDL) and oxidized high-density lipoprotein (oxHDL), known as risk factors for cardiovascular disease, have been observed in plasma and atheromatous plaques. In a previous study, the content of oxidized phosphatidyl
Externí odkaz:
https://doaj.org/article/461cbb6d5a0541fb97dbfb313a8ac042
Autor:
Kohei Maeda, Toshihiro Tanioka, Rei Takahashi, Hideaki Watanabe, Hirohiko Sueki, Masafumi Takimoto, Shin-ichi Hashimoto, Kazuho Ikeo, Yusuke Miwa, Tsuyoshi Kasama, Sanju Iwamoto
Publikováno v:
The Journal of Immunology.
Recent studies have highlighted the pathogenic roles of IL-17–producing CD8+ T cells (T-cytotoxic 17 [Tc17]) in psoriasis. However, the underlying mechanisms of Tc17 induction remain unclear. In this study, we focused on the pathogenic subsets of T
Autor:
Junji Tsurutani, Yuji Kiuchi, Ryotaro Ohkuma, Norihiro Suzuki, Sanju Iwamoto, Hirotsugu Ariizumi, Atsushi Horiike, Yuya Hirasawa, Hiroo Ishida, Midori Shida, Shinichi Kobayashi, Kazuyuki Hamada, Satoshi Wada, Hiroto Matsui, Kiyoshi Yoshimura, Tomoyuki Ishiguro, Makoto Taniguchi, Yutaro Kubota, Naoki Uchida, Takuya Tsunoda, Takehiko Sambe
Publikováno v:
In Vivo
Background/aim Rapid tumor growth after administration of immune checkpoint inhibitors is designated hyper progressive disease (HPD). In this study, besides the conventional HPD category, we proposed the "super HPD" category where the disease is natu
Publikováno v:
The Showa University Journal of Medical Sciences. 33:67-73
Publikováno v:
The Showa University Journal of Medical Sciences. 32:135-145
Publikováno v:
Biologicalpharmaceutical bulletin. 44(7)
Angiotensin III (Ang III) is a heptapeptide derived from Ang II that has been confirmed as the preferred agonist of angiotensin II type 2 receptor (AT2R). Recent studies have revealed AT2R mainly exerts anti-inflammation effects. However, the effects
Autor:
Takashi Obama, Toshihiro Aiuchi, Sanju Iwamoto, Kiyoshi Fukuhara, Tomohiko Makiyama, Mirei Mizuno, Hiroyuki Itabe, Naoko Sawada
Publikováno v:
Antioxidants, Vol 9, Iss 1045, p 1045 (2020)
Antioxidants
Volume 9
Issue 11
Antioxidants
Volume 9
Issue 11
Oxidized low-density lipoprotein (oxLDL) and oxidized high-density lipoprotein (oxHDL), known as risk factors for cardiovascular disease, have been observed in plasma and atheromatous plaques. In a previous study, the content of oxidized phosphatidyl
Autor:
Kazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, Yuya Hirasawa, Hirotsugu Ariizumi, Ryotaro Ohkuma, Midori Shida, Yutaro Kubota, Hiroto Matsui, Tomoyuki Ishiguro, Takehiko Sambe, Hiroo Ishida, Atsushi Horiike, Satoshi Wada, Sanju Iwamoto, Naoki Uchida, Yoshio Ogawa, Shinichi Kobayashi, Takuya Tsunoda
Publikováno v:
Medicine. 101:e28339